Close
Show
Home Articles Page 16

Articles

The knowledge-based articles provided in this section are a collection of view points from research professionals and experts concerning various aspects of Pharmaceutical industry such as Drug Research, Pharmaceutical Production and Manufacturing, Strategies, Clinical Trails and Information technology.

Academia-Industry Collaborations for Pharmaceutical Innovation

A Powerful Pairing: Academia-Industry Collaborations for Pharmaceutical Innovation

Chiesi Group Online Topics Drug Research
Innovation is unarguably the essence of pharmaceutical discovery and development. Industry and academia have been working together for decades, but historically relationships did not extend far beyond the traditional exchange of funding and research....
Considerations for Purchasing Antibodies

Top Three Considerations for Purchasing Antibodies

Antibodies.com Online Topics
Antibodies are widely used in pre-clinical research to study proteins and their functions in biological pathways and diseased states. These tools, with their high specificity and sensitivity, help life science researchers to easily identify...

Steps to Compliance: How Best to Prepare for Russia’s 2020 Pharma Regulations

rfxcel – Track and Trace Software Print Issue August 2019
Preparing for Russia’s regulation requirements might seem like a mountain to climb, but it’s a necessary journey for companies that want to remain in or enter the 10th largest pharmaceutical market in the world. With...

Data Collection in Phase II-III Clinical Research – It is Ripe for Disruption?

ICON plc Print Issue April 2019 Clinical Trials
Current data collection practices in clinical research are facing many challenges. There is a broad recognition that issues prevail with the current clinical research data collection processes and systems. Industry leaders, such as Janet Woodcock,...

Why AI in Drug Discovery has Yet to Live Up to its Promise!

Elsevier Print Issue April 2019 Drug Research IT & Data Management
Being a life sciences researcher today involves being inundated with data from every direction. Every day, new studies are published, conferences held, and experiments conducted. Despite rumours the age of the ‘blockbuster’ drug might be...

First step to Secondary Packaging: Start with the End in Mind

Online Topics
No matter if it is meeting the needs of a rapidly aging market, blocking drug counterfeiters or differentiating your pharmaceutical product in the market, a secondary packaging program is essential to achieve success. However,...

The Essential Role of Interactive Response Technology (IRT) in Clinical Trial Supply

Sharp Print Issue April 2019 Clinical Trials
Increasingly elaborate international clinical trials are demanding a smarter, streamlined approach from supply partners and better collaboration with sponsors. In this environment, Interactive Response Technology (IRT) systems have been a staple and a powerful, practical...

IoT Is the Key to Supply Chain Continuity, Visibility, and Productivity

rfxcel – Track and Trace Software Print Issue April 2019 IT & Data Management Packaging & Labelling
As the global logistics and supply chain industry continues to grow — it is expected to reach $15.5 trillion by 2023 — pharmaceutical companies are facing more hurdles than ever to monitor their cargo...

The Highest Safety for Highly Potent Pharmaceuticals

Bosch Packaging Technology Print Issue April 2019 Packaging & Labelling
Biotechnologically manufactured drugs are one of the most important pharmaceutical trends of the past years. Especially in cancer therapy, the advent of antibody-drug conjugates (ADCs) has opened the door for new, extremely promising treatment...

New Independent Study proves Coated Lidding Significantly reduces Packaging-related Particulate in Drug Delivery Systems*

Oliver Healthcare Packaging Print Issue April 2019 Packaging & Labelling
Coating technologies reduce particulate generation by up to 96% in pharmaceutical manufacturing. As the demand for prefilled and prefillable syringe applications grow, one consideration for many pharmaceutical manufacturers is particulate; in particular, how particulate can...